论文标题
瓦尔多在哪里? Miccai 2021的血管病变检测和分割挑战
Where is VALDO? VAscular Lesions Detection and segmentatiOn challenge at MICCAI 2021
论文作者
论文摘要
脑小血管疾病的成像标记提供了有关大脑健康的有价值信息,但是它们的手动评估既耗时又受到实质性内部和间际可变性的阻碍。自动化评级可能受益于生物医学研究以及临床评估,但是现有算法的诊断可靠性尚不清楚。 Here, we present the results of the \textit{VAscular Lesions DetectiOn and Segmentation} (\textit{Where is VALDO?}) challenge that was run as a satellite event at the international conference on Medical Image Computing and Computer Aided Intervention (MICCAI) 2021. This challenge aimed to promote the development of methods for automated detection and segmentation of small and sparse imaging markers of cerebral small vessel disease,即血管周间空间(EPVS)(任务1),脑微孔(任务2)和假定的血管起源(任务3)的间隙,同时利用弱且嘈杂的标签。总体而言,有12个团队参与了针对一个或多个任务的解决方案的挑战(任务1 -EPVS 4,任务2 -Microbleeds的9个,任务3 -lacunes的6个)。多方数据在培训和评估中都使用。结果表明,整个团队和跨任务的性能差异很大,对于任务1- EPV和任务2-微型造成的有希望的结果,对于任务3 -lacunes而言尚无实际的结果。它还强调了可能阻止个人级别使用的情况下的性能不一致,同时仍证明在人群层面上有用。
Imaging markers of cerebral small vessel disease provide valuable information on brain health, but their manual assessment is time-consuming and hampered by substantial intra- and interrater variability. Automated rating may benefit biomedical research, as well as clinical assessment, but diagnostic reliability of existing algorithms is unknown. Here, we present the results of the \textit{VAscular Lesions DetectiOn and Segmentation} (\textit{Where is VALDO?}) challenge that was run as a satellite event at the international conference on Medical Image Computing and Computer Aided Intervention (MICCAI) 2021. This challenge aimed to promote the development of methods for automated detection and segmentation of small and sparse imaging markers of cerebral small vessel disease, namely enlarged perivascular spaces (EPVS) (Task 1), cerebral microbleeds (Task 2) and lacunes of presumed vascular origin (Task 3) while leveraging weak and noisy labels. Overall, 12 teams participated in the challenge proposing solutions for one or more tasks (4 for Task 1 - EPVS, 9 for Task 2 - Microbleeds and 6 for Task 3 - Lacunes). Multi-cohort data was used in both training and evaluation. Results showed a large variability in performance both across teams and across tasks, with promising results notably for Task 1 - EPVS and Task 2 - Microbleeds and not practically useful results yet for Task 3 - Lacunes. It also highlighted the performance inconsistency across cases that may deter use at an individual level, while still proving useful at a population level.